By Rai Umraopati Ray ▶️ Vaxzevria significantly boosted antibody levels against Omicron ▶️ Insurers received 9.5L Covid-19 treatment-related claims in FY21 ▶️ People’s support critical for curtailing further spread...
Read more
By Rai Umraopati Ray ▶️ WHO experts recommend a third dose of Novavax COVID vaccine for people with health issues ▶️ AstraZeneca, Oxford aim to produce an...
Read more
By Rai Umraopati Ray ▶️ Gum Disease Increases Risk of Other Illness Such as Mental Health and Heart Conditions, Study Suggests ▶️ New Research Moves Closer to Harnessing Viruses...
Read more
By Rai Umraopati Ray ▶️ Astrazeneca's Evusheld retains neutralising activity against Omicron ▶️ India medical devices market to witness 7 per cent growth through 2025: GlobalData ▶️ 135.99 cr...
Read more
By Rai Umraopati Ray ▶️ Innovaccer raises $150 million Series E round at $3.2 billion valuation ▶️ India reports 7,974 new Covid-19 cases in the last 24 hours; active...
Read more
By Rai Umraopati Ray ▶️ EU regulator backs J&J COVID-19 booster dose for adults ▶️ COVID-19 vaccines may be less effective against Omicron: WHO ▶️ Centre reviews Commissioning, Installation...
Read more
By Rai Umraopati Ray ▶️ Pfizer vaccine protecting against hospitalisation during Omicron wave: Study ▶️ Healthians and QRX join hands to launch rapid PCR testing for COVID-19 ▶️ More...
Read more
By Rai Umraopati Ray ▶️ 'Phenomenal' Omicron spread accounts for 40% of London infections ▶️ Omicron poses 'very high' global risk but data on severity limited - WHO ▶️...
Read moreBy Rai Umraopati Ray ▶️ GSK says antibody drug 'Sotrovimab' works against Omicron ▶️ Second dose coverage jumps by 11.7 per cent: Centre ▶️ 124.96 cr...
Read more
By Rai Umraopati Ray ▶️ Delhi govt fully prepared to deal with new coronavirus variant Omicron: Satyendar Jain ▶️ Star Health IPO subscribed 12% on debut; plans...
Read more
